Lecture 9 & 10 (tyrosine kinases) Flashcards
Two forms of tyrosine kinases
- Receptor tyrosine kinases
- Non-RTKs
A common mechanism to regulate protein function
Phosphorylation
Is phosphorylation reversible?
Yes
__ kinases function in the early steps of signal transduction, whereas __ kinases function at later steps.
Tyrosine kinases
Serine/threonine kinases
Receptors for known tyrosine kinases
- EGF receptor (ErbB)
- CSF-1 receptor (fms)
- PDGF receptor
- Insulin receptor
- IGF-1 receptor
- FGF receptor
First tyrosine kinase discovered
Src gene
General features of kinases
- All have similar catalytic domains
- 250-300 amino acids
- Differences in this domain distinguish tyrosine kinases from serine/threonine kinases
Related structural features of RTKs
Ligand binding domain in N-terminal extracellular region (25 aa hydrophobic region spanning the membrane)
v-ErbB (oncogene)
- truncated version of ErbB (EGFR)
- lacks N-terminal extracellular domain → receptor constitutively activated
- amplification occurs in many tumours e.g. glioblastomas, squamous cell carcinomas
Fms oncogene
- derived from CSF-1
- not deleted but has an activating point mutation in the extracellular domain
- deletions of the extreme -COOH end also positively regulates transforming activity
Other oncogenes that encode RTKs
Ros, Sea, Rrk, Met, Ret Kit
N-terminal deletions have been found in…
ErbB2, Kit, Ros, Met, Ret and Trk oncogenes
Example of a tyrosine kinase inhibitor
Lapatinib
How does Herceptin (Trastuzumab) work?
mAb binds the ligand-binding domain of HER2 & stops the growth factor from binding
Benefit of administering Herceptin in combination with a tyrosine kinase inhibitor
Herceptin inhibits ligand-binding domain of HER2, TKI inhibits catalytic domain of HER2